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AMERICAN JOURNAL OF EVALUATION, 25(1), 2004 health care claims data, which usually are administered by a third party, the corporation collects these data and grants permission to use them.
Studies of worker health, including evaluations of workplace programs, are often based on corporate data, usually medical claims records (Dimberg et al., 2002; Liese, Mundt, Dell, Nagy, & Demure, 1997; Reeve et al., 1998; Smith, Dannenberg, & Amoroso, 2000) . Many companies use the data internally to evaluate health risk factors and workplace programs (Dimberg et al., 2002; Liese et al., 1997; Reeve et al., 1998) . Some corporations maintain research units that are primarily funded by outside sources and often the corporation collaborates with academic researchers (Selby, 1997) . However, few "outsiders" (third parties with no ties to the corporation) have used corporate data because it is difficult to obtain access (Reville, Bhattacharya, & Sager Weinstein, 2001 ). In light of new federal regulations, gaining access to these data is even more complicated and intimidating. This paper discusses the impact of federal regulations on the use of corporate data in research, the potential of corporate data in evaluation studies, the challenges to obtaining and using these data, and finally, study designs that make use of corporate data.
HOW DO FEDERAL REGULATIONS IMPACT THE USE OF CORPORATE DATA IN RESEARCH? Health Insurance Portability and Accountability Act of 1996: The Privacy Rule
The Privacy Rule was issued under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) within the administration simplification provisions. These provisions were intended to reduce the costs of health care financing by standardizing the electronic communication of data. The Privacy Rule governs the use and disclosure of "Protected Health Information" (PHI). PHI is individually identifiable health information in any form, electronic and non-electronic, that is held or transmitted by a covered entity. "Covered entities" include health plans, health care providers that file claims electronically, and health care data clearing houses.
HIPAA has important implications for epidemiologic research because PHI is necessary in many study designs (CDC, 2003) . PHI include personal identifiers (name, social security numbers, etc.) in addition to information about a person's past, present, or future physical or mental health, the provision of health care, or payment for health care, that a covered entity creates or receives. PHI is particularly important to epidemiologic studies because personal identifying information allows researchers to follow individuals over time, and to link between data sets and within a data set (Black, 2003) .
If a HIPAA covered entity is the custodian ("owner") of the data, then they must comply with the new Privacy Rule. In order to retain personal identifiers on the data set the researchers have to obtain consent from every individual for use of their PHI or, more realistically, if the study population is large, obtain a waiver from an Institutional Review Board (IRB) or Privacy Board.
Some forms of corporate data fall under HIPAA, including claims records kept by a health care provider and EAP records where EAP services are provided by a third party and records are kept by a covered entity. HIPAA does not, however, preempt laws for the conduct of public health surveillance, including surveillance collected for federal reporting, investigation, or intervention. HIPAA also does not govern non-health related corporate data kept by the
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corporation, including personnel, disciplinary, drug testing and absentee records. However, if the research institution receives federal grant funds, protection of confidentiality with review by an IRB will still apply under the Common Rule (Protection of Human Subjects).
Federal Policy for the Protection of Human Subjects (Part A), "Common Rule"
The Common Rule was developed to protect human subjects in research funded by or regulated under a federal agency or research undertaken by an institution that has filed an assurance with the federal government (DHHS, 2001) . If your institution has a multiple approval IRB as part of its federal-wide assurance, the IRB must certify that all research at the institution will meet human subjects protections, even privately funded research. Without such an IRB, the common rule would not apply. Human subjects are living individuals about whom a researcher obtains data through intervention or interaction or identifiable private information. Private information is individually identifiable and includes information for specific purposes (such as a medical record) that individuals can reasonably expect will not be made public. This rule requires that data be rendered harmless by removing personal identifiers. Unlike the HIPAA Privacy Rule, the Common Rule does not stipulate what type of information is classified as "identifying."
Employee Retirement Income Security Act of 1974
To further complicate the use of corporate data, research may be impacted by regulations imposed by the Employee Retirement Income Security Act of 1974 (ERISA). This federal law sets minimum standards for most voluntarily established pension and health plans in private industry to provide protection for individuals in these plans. Prior to HIPAA, ERISA allowed a corporation to access its employees' health care records and protections of employee information were at the discretion of the corporation. Post-HIPAA, ERISA regulations are superseded by HIPAA in cases where data are administered by a "covered entity." Further, state privacy laws, if more stringent than HIPAA rule, can restrict access of outside researchers to employee data unless the researcher is made a contractor ("insider") to the corporation.
CHALLENGES IN OBTAINING AND USING CORPORATE DATA
Because of the wide variety of information corporate data provide on large well-defined populations of workers over time and the ability to link between data sources, these data are useful for occupational health research, including workplace program evaluation. However, access to these data is hindered because of corporations' reluctance to share information with outsiders and concerns regarding both employee and employer confidentiality. In the current HIPAA privacy era, the most important issues to researchers interested in using corporate data are gaining access, guarding employer and employee confidentiality, and maximizing the research potential of corporate data by linking the data sets. This section of the article discusses these issues and possible ways to address them. We also provide examples of our own experience with corporate data in evaluating a workplace substance abuse prevention and early intervention program at a large U.S. transportation company. Table 1 summarizes the challenges and steps we took to overcome these obstacles. • Designed a protocol that met with union, management, and IRB approval • Must meet IRB approval and comply with HIPAA
• Replaced identifying information with a random study number for each worker
• Must find a way to retain the "linkability" of the data sets without personal identifiers • Mishandling data could create labor relations problems
Data availability
• Different data sets managed by different departments
• Negotiated with each "owner" of the data • Some data not centrally collected
• Had to weigh the cost of collecting and automating the data against their usefulness in the analysis
• Some data not automated
Data quality
• Data systems were created for • Probabilistic matching for administrative use, not research
• Tested sample files • Information not always complete
• Some information we did without • Free text fields must be coded
Retrospective analysis
• Data not available for the entire period
• Used only information available for the entire study period • Data system has changed and/or
• Changed the study period been modified
• Changed the study design • Data collection methods have changed or been modified
• Located a vendor that could convert old files • Latest information overwrites prior data • Files were archived under a prior computer environment
Access
Access is the ability to obtain and use the data and presents the initial hurdle to getting a study underway. For researchers and evaluators outside the corporation, gaining access to corporate data requires tremendous time, energy, and patience. Access can be both hindered and helped by corporate culture and the relationship of the researcher with corporate management and, where applicable, the unions.
Corporate culture will influence the extent to which the data are shared with "outsiders" and the corporation's commitment and cooperation with the evaluator. A corporate culture is based on shared ideologies and defines what is right and wrong to feel, think, and do (Trice, 1993) . These rules are not rational or neutral, but charged with emotion. The "we-ness" that a corporate culture creates calls upon members to be loyal insiders.
The size and strength of union organization in the workforce will heavily influence a corporate culture. According to the ideals of unionism-"We are our brother's keeper"-confidentiality and trust are of the utmost importance. Some unionized workforces tend toward adversarial distrust of management. Any management mishandling of the release of data can hamper labor relations.
Partnerships between private companies and outside researchers are not new (Goldman, Sturm, & McCulloch, 1999) . In general, outside researchers are perceived as unbiased and their findings are more likely accepted by the public. This sort of partnership is often sought out by pharmaceutical companies needing an unbiased third party to test their product. However, sometimes researchers are pegged as biased simply by association.
Frequently there are predetermined opinions of the program being evaluated and these opinions can run along union/management lines. In our study company, some friction existed between union and management. To avoid being perceived as supporting either "side," we stressed that we were unbiased researchers whose only agenda was the evaluation of the program. This was consistently reinforced in meetings and presentations. Steering committee meetings, where leaders from all sectors of the workforce participated, were especially useful for this purpose.
In addition, if the results are not to the corporation's liking, an attempt might be made to block the release of the findings (Rennie, 1997) . The researcher has an obligation to release their unbiased findings even if the corporation's product is at stake (Dreyer, Loughlin, & Rothman, 1999; Rennie, 1997) . In fact, most universities forbid their researchers to sign agreements that put restrictions on the right to publish.
Any legal wrangling resulting from problems with the project can be avoided if, before the research project begins, all parties involved in the partnership understand each other's objectives for the research and the sensitivities and potential ramifications of the research findings. Dreyer (2001) discusses how researchers can avoid problems and recommends written agreement to terms of the research engagement and ground rules.
Gaining access to the records needed for our evaluation of a workplace substance abuse program was a particular challenge because each of the six data sets was administered by a different department. Therefore we had to enter into six different negotiations and not all resulted in permission to use the data. The four years it took to finish negotiations required persistence and patience. We found it useful to have a short, easy-to-read description of the project that explained the use of each data source.
Once data access is obtained, it is useful to have corporate staff explain what their data systems can do. Ideally, a research staff person can work on-site to be trained to use the data as a corporate employee would. In one project, we sent an employee on-site who was treated as an entry-level employee. Once trained, the employee started running simple queries with the data for his company supervisor and eventually performed more sophisticated analyses. Both the evaluators and the corporation profited and their relationship also benefited.
Our experience taught us that understanding the corporate culture and forging key relationships without alienating anyone is important. One way to connect with all sides is to help each understand the benefits to them. A benefit can be the building of a system for future data collection, synthesizing historical information, or sharing graphs and materials generated by the analysis of data, in addition to the outcome of the evaluation itself. Other studies using multiple corporate data sets had similar experiences (Goldman et al., 1999; Reeve et al., 1998) . Their collaborations were successful and productive because of strong support from senior management and, where applicable, the unions in addition to a significant level of trust between parties.
Confidentiality
Protection of an individual's confidentiality is an issue for anyone with access to individuallevel data. With conflicting federal and state regulations, companies are often uncertain of what legally can be shared. Legal ground for data release is even less clear with corporate-held records than with government program records or medical claims data.
The new HIPAA regulations establish concrete guidelines that data custodians can follow to protect individual confidentiality while still being able to share their data with research teams that have followed the proper procedures. De-identified data (ones that do not contain the 18 PHI as defined by HIPAA) may be used for research purposes, though their usefulness is limited because they contain no dates to track individuals over time and no identifiers to link between and/or within data sets. If the researchers specify acceptable uses and disclosures of the data and do not attempt to re-identify or contact individuals, they can use a "limited data set," which retains broad geographic identifiers and elements of dates (e.g., year, birth date) that do not directly identify the individual. Alternatively, rather than accrue data on individual employees, it may be possible to analyze collapsed data by worksite, union, year, month, etc.
If the researcher wants access to data that include personal identifiers, several methods can be used to address confidentiality. Informed consent can be obtained from every individual whose information is used. However, this is impractical if the study population is large. A more common approach is to develop a research protocol that addresses privacy issues. A waiver is given if the IRB determines the use of PHI involves no more than "minimal risk" to the privacy of the individuals (DHHS, 2001) . Once this protocol is approved by an IRB, data can be used without a person's consent.
Confidentiality was of the utmost importance to our study company and was the primary issue for all data custodians considering giving us access. Several re-checked with their legal department to be sure data access had been approved. For our project we had to guard both confidentiality of employees and the company. Because the company's identity might be deduced if the specific industry was named, we simply referred to the industry as "transportation." A negative consequence of withholding this type of information is that information is lost that might be important in interpreting our results, such as characteristics unique to that industry, the workers, worker culture, and industry history.
To gain the corporation's trust, in our case, each researcher signed a confidentiality pledge. Our institution reached an indemnity agreement with the unions and corporation that protected them against unapproved release of individual identification and we verified that our liability insurance covered the risk. One stipulation we imposed in these negotiations was that we would not share the raw, individual-level data with departments other than the original data custodian (e.g., not sharing union, EAP, or health care data with the corporation). Indemnifications relate to distribution of risk and blame should the project result in any harm, emotional or physical. It is important to get written non-owner agreements. Our organization once had a company decide, midway through a study, that they wanted to access the individual data we had collected, including PHI. A written agreement, as recommended by Dreyer (2001) , could have avoided some legal wrangling and rancor that followed.
Linkage
One reason for the extra effort to access personal identifiers is to be able to link the data sets (Black, 2003) . Because corporate data come from multiple sources, identifiers are used to link between and within data sets, follow individuals over time, combine health and work history, and create a large population-based health database with a large variety of worker and workplace information. Sorock et al. (1997) , for example, recommended increased use of linked data sets in order to get a more comprehensive estimate of the number and type of occupational injuries.
Most of the data collected by companies on the individual worker can be linked using identifiers common to all data sets. These identifiers include employee number, social security number, name, birth date, or, most effectively, all available means of identification (Kelman, Bass, & Holman, 2002) . One Privacy Rule stipulation to being granted access to personal identifiers is that these identifiers be removed at the earliest possible moment. To retain "linkability" without personal identifiers an anonymous, unique number or number-character combination is assigned to each individual. The key that links the anonymous identifier with the personal identifying information must be kept separate and secured.
In this era of user-friendly computer software and electronic data there are many ways to "strip" the identifiers in order to assign an anonymous, unique code to each individual. Berman (2002a Berman ( , 2002b describes several new computational techniques. For our evaluation we used a SAS computer program that replaced all identifying information with a random number for each individual by using the "ranuni" command. Other statistical software packages (e.g., SPSS, Stata) have similar abilities. The program was run on data containing personal identifiers at the earliest possible moment (on corporate property, in most cases). The key that linked the study number to the identifiers was stored on a password-protected diskette in a locked cabinet. Only one researcher was allowed access to this diskette.
In cases where data have no personal identifiers or identifiers are not unique enough, one can use probabilistic matching to link data sets. In probabilistic record linkage two or more records are compared to determine whether those records refer to the same person (Howe, 1998; Jaro, 1995) . A computer program estimates the probability that the records refer to the same person.
Linking data facilitates the creation of a variety of data sets custom designed to meet the needs of the research project. These adaptable data permit more rigorous study designs and biostatistical analyses.
STUDY DESIGNS FOR WORKPLACE PROGRAM EVALUATION USING CORPORATE DATA
Even with the wealth of information that linked corporate data sets provide, many challenges exist for evaluation studies. Often not all longitudinal data needed for a cohort study are available. The longer the study period, the more likely that data will not be available for the entire period and the more likely that data systems, data elements, and collection methods have changed. If information on duration of leaves of absence and suspensions are unavailable, then exposure measures (e.g., work days, worker hours, full time equivalent employees) are inexact. In addition, if data are available for only a portion of the workforce, generalizability of the results is at risk and the evaluators must make assumptions regarding the behavior of the missing workers when interpreting the results. Finally, if the impact examined is a relatively rare occurrence (e.g., fatal injury) then a cohort study is not efficient unless many years of data are available. However, there are a variety of methods that can overcome these challenges. First, linking multiple data sources that collect information about the problem being studied permits a better understanding of reporting trends for different data sources and a more comprehensive tally of the magnitude of the problem. For example, Peek-Asa, Schaffer, Kraus, and Howard (1998) linked police and employer reports of non-fatal workplace assault injuries and eliminated duplicates. They found that the annualized rate of assault injury was almost twice the rate found in either reporting source individually.
Cohort studies take advantage of the cohort of workers for which human resource data exist. This could be a snapshot of the active workforce on the day the data were retrieved from the human resource department. Even better, a cohort study could use data on the workforce over some defined period that includes separations. Linking the cohort to other data sets permits a robust population-based analysis that takes advantage of the data available. If data are available both before and after the intervention, time series methods can measure variation in the outcome among a cohort of workers (Pelletier, 2001; Serxner, Gold, Anderson, & Williams, 2001; Tarlo, 1999) .
Where individual-level data are not available, time series methods based on collapsed groups (worksites, unions, etc.) are a viable, and sometimes preferable, alternative. If using a single time series (e.g., injury rates at one company over time), interrupted time series methods are a possibility (Madden et al., 2002; Miller, Zaloshnja, & Spicer, 2003) . Interrupted time series is a quasi-experimental design that often uses regression techniques to determine if the outcome variable changed significantly after implementation of the intervention.
Cross-sectional time series data (or panel data), such as injury rates at several worksites over time, is particularly powerful because the statistical methods capitalize on two sources of variation, over time and cross-sectionally (Brickmayer & Hemenway, 1999; Spicer, 2003; Zwerling & Jones, 1999) . By comparing worksites, companies, and the like, over time, factors are controlled for that simultaneously affect all cross-sections and confound the relationship between the variable of interest and outcome.
If no pre-intervention data are available, one can model the outcome based on variation of an independent variable that measures program activity or usage that changes over time (Miller et al., 2003; Spicer, Miller, Durkin, & Barlow, in press ). In addition, one can compare groups that vary in level of exposure to the intervention. Another possibility is using a natural control group that did not receive the intervention for reasons that are not related to the risk factor or outcome being addressed by the intervention.
Time series techniques are complex and researchers must understand the inherent assumptions regarding the data for each different method. Current advances in statistical software do a lot of the programming and provide more options and modifications than ever before. However, time series studies require a wealth of information that is often incomplete for parts of the study period (time series). For example, if evaluating the impact of a program on injury rates the size of the workforce must be known for each time period to control for any changes in number of employees. If this information is not available it must be estimated or assumed not to vary.
Case-control studies maneuver around several of the above data limitations: They are not population-based, do not require that data exist on the entire cohort of workers, and are powerful when the impact being examined is a relatively rare event. Case control studies compare one group to another based on the outcome or the exposure (intervention or risk factor) (Lincoln, Feuerstein, Shaw, & Miller, 2002; Ore, 2002; Tarlo, 1999) . Case control studies don't have to involve complicated regression techniques. One can compare the desired outcome among an intervention group (cases) versus a non-intervention group (control) in the pre-versus post-intervention period (Spicer et al., in press) . If the two groups are similar in all characteristics other than the intervention, then any change beyond that seen in the control group is attributed to the intervention.
One or more controls can be "matched" to each case by one or more characteristics (e.g., sex, age) known to be a confounder in the relationship between the outcome and the intervention (Klassen, Smith, Meissner, Curbow, & Mandelblatt, 2002) . Matching in a case control design establishes better comparability between cases and controls and improves the statistical efficiency of the regression model. Regression analysis models the likelihood that the case was the injured person within the matched group. If time is a factor, then controls can be matched to cases by the time of the outcome (e.g., employed at the time of the injury) or the length of employment.
Choosing the appropriate study design depends on the evaluation question and requires an understanding of the strengths and limitations of the data available. Because most corporate data sets are designed for administrative rather than research use, underreporting of workplace injuries and illnesses is common (Pransky, Snyder, Dembe, & Himmelstein, 1999) . Evaluators should understand the biases that data limitations introduce to the study. In addition, for each study design there are a number of difficult methodological issues to consider. However, with the wealth of information available from corporate data and the added advantages of linked data, workplace program evaluations can be rigorous enough to answer questions regarding effectiveness.
CONCLUSION
Corporate data are a largely untapped source for occupational health research, including program evaluation. Forming partnerships with companies and unions and gaining access to corporate data can be intimidating. By building relationships with companies interested in improving the health and safety of their employees, by understanding federal regulations on the use and disclosure of PHI, and by designing a solid protocol for protecting confidentiality and linking data sets, researchers can to take advantage of the available worker and workplace information and improve our understanding of worker health and safety.
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